Use Risen, Cowdery, Spoelman and Haskell, Offringa, Rothbaum, and Wondrich for the multi-source structure. Use the linked exact timeline events for primary or contemporaneous anchors.
Prohibition eliminated legal production capacity, firms, skills, and inventory while regulated medicinal-whiskey channels preserved and reallocated selected stocks and brands. After Repeal, licensing, plant restart, inventory finance, aging time, distribution, and acquisition requirements favored firms with greater capital and scalable portfolios, concentrating control in a smaller group of producers and brand owners.
Verified at the thematic-period level on 2026-09-01. Exact counts and individual transactions remain in subordinate claim/event records with their own confidence levels; they are not prerequisites for this bounded structural statement.
This is a structural interpretation, not a claim that medicinal permits were the sole cause or that every region followed the same timetable. It does not assert an exact national survivor count, rank every transaction, or quantify each mechanism's causal weight.
Nine verified source locators independently converge on plant loss, restricted medicinal channels, brand and inventory transfers, capital-intensive restart, portfolio acquisition, and post-Repeal concentration. Exact events supply bounded examples without requiring a single exhaustive corporate chronology.
Supported / Strong / High remains unchanged. LOCAL-046 adds independent practitioner corroboration; ZET-53 remains Established. September 29 full-copy Offringa audit: Offringa's PDF 182–193 supplies broad consolidation context only, not firm-level evidence or independent confirmation of every mechanism in the claim. Exclude its erroneous Prohibition threshold and compressed federal-agency succession. Existing confidence, maturity, other-source evidence and public uses are unchanged.
Claim
Prohibition removed legal production capacity and shifted selected stocks and brands through restricted medicinal-whiskey channels. Repeal created a capital-intensive restart in which licensing, plant, inventory, aging, distribution, and acquisition requirements favored firms able to operate at scale.
Evidence
Nine verified locators from multiple independent histories converge on plant loss, restricted medicinal channels, brand and inventory transfers, cross-border capital, portfolio acquisition, and post-Repeal concentration. Linked exact events add bounded evidence for prescription controls, named production allotments, a 1923 corporate and warehouse transfer, and the fiscal-1947 Big Four market snapshot.
Qualification
This is a structural interpretation, not a national firm census. State timing varied, medicinal whiskey was one mechanism among several, and exact counts or transaction histories must come from subordinate records.
Readiness
Ready for Drafting with Strong evidence, High confidence, verified locators, and explicit limits on granularity.